Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only. Codename:Pepe is merging AI with memecoin culture, ...

10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports.

Popcorn is one of my all-time favorite snacks, especially now that I have to eat gluten-free. It's a quick way to fill me up without having to worry about what's in it. Whether it's buttery movie ...

10x Genomics has a fifty-two week low of $9.77 and a fifty-two week high of $45.60. The firm’s 50 day moving average price is $13.90 and its 200 day moving average price is $16.67. Get 10x ...

This month's cover highlights the article Nup358 restricts ER-mitochondria connectivity by modulating mTORC2/Akt/GSK3β signalling by Joseph, Misha Kalarikkal and colleagues. The image shows a human ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Functional genomics uses genomic data to study gene and protein expression and function on a global scale (genome-wide or system-wide), focusing on gene transcription, translation and protein ...

"By transforming questions about metabolism into a genomics challenge, we were able to draw a 'wiring map' of adult worm metabolism that revealed numerous novel insights." "The most exciting part ...

It features a software stock we’re confident has 10X potential. Road sign showing a fork in the road Philip Panaro is the founder and former CEO of Boston Consulting Group who clearly remains ...

Imagine an AI system capable of guiding a robot to manipulate physical objects as effortlessly as it navigates software menus. Such seamless integration of digital and physical tasks has long been the ...

Assets in the region span medtech/medical device development and manufacturing, bioinformatics, genomics, nutrition, human health, clinical research, and, increasingly, biopharma manufacturers.